Use of step therapy protocols prohibition for the treatment of neurological conditions

Summary

The bill bars health insurers from forcing patients with neurological disorders to follow step‑therapy protocols when a prescribed drug is FDA‑approved and listed on the plan’s formulary. It applies only when the drug’s use matches its FDA indication and a clinical practice guideline. The rule takes effect on Jan. 1, 2027 for plans issued or renewed after that date.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share